Consistent with their roles in cellular fatty acid metabolism, activation of PPARs by agonists such as fibrates (PPARα) and thiazolidinediones (PPARγ) has demonstrated clinical efficacy in treating metabolic disorders in humans (9, –, 11). The gene discussed is PPARA; the disease is Other metabolic disease.